Gordon Findlay Biography – Gordon Findlay Wiki

Gordon Findlay, serving as the global brand director at Novo Nordisk since 2023, oversees various marketing roles, including strategic marketing, new product planning, and global outreach. The headquarters of Novo Nordisk are in Bagsværd, Denmark, but Findlay operates out of Basel, Switzerland.

His extensive experience is highlighted on his LinkedIn profile, showing a notable tenure at Novartis. While at Novartis, a leading pharmaceutical company also based in Basel, he held various significant positions. These included directing Global New Product Development from January 2016 to September 2023, managing the Global Marketing and Primary Care Franchise from January 2012 to December 2015, and leading Global Strategic Marketing from March 2010 to December 2011.

In addition to these roles, Findlay briefly held the position of marketing director at Novartis UK from January to June 2019. Before his time at Novartis, he was the director of Worldwide Commercial Development at Pfizer, a role he fulfilled from October 2001 to March 2010.

Academically, Findlay is well-equipped with a PhD in Biochemistry from the University of Kent. He also possesses an MBA from The Open University and a BSc in Biochemistry/Immunology from the University of Strathclyde.

Gordon Findlay Age

Details about Gordon Findlay’s age remain undisclosed to the public.

Gordon Findlay Collapse

Novo Nordisk executive Gordon Findlay reportedly collapsed in the Oval Office during an event where President Trump made a statement on lowering the price of weight-loss drugs, including Ozempic.

David Ricks, CEO of Eli Lilly, was giving remarks when he looked to his right and said, “Are you okay? Gordon, are you okay?” Dr. Mehmet Oz jumped in as the drug executive fell to his knees and collapsed. The press were then ushered out and asked to leave. Robert F. Kennedy Jr., the U.S. Health and Human Services Secretary, was also in the room when the incident happened.

About 30 minutes later, when the press conference resumed, Trump gave an update on the executive’s health.

“One of the representatives of the companies, of one of these companies, got a little bit lightheaded,” he told the press. “We saw he went down, and he’s fine. They just sent him out, and he’s got doctors here. But he’s fine.”

The man was identified as Gordon Findlay, the global brand director for Novo Nordisk, though the pharmaceutical company later shared a statement with multiple outlets suggesting that Findlay was not present at the event.

“Please be aware that CEO Mike Doustdar and EVP, US Operations, Dave Moore were the only two Novo Nordisk representatives in the Oval Office,” a spokesperson for Novo Nordisk said in a statement.